| abstract |
The invention described herein relates to certain 2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidme-7-carboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example. |